About 41 Trademarks found that are owned by Salix Pharmaceuticals Inc.

prescription pharmaceutical preparations for the treatment and prevention of gastrointestinal diseases and disorders in humans

Providing health information

Pharmaceutical preparations and substances for the treatment and/or alleviation of gastrointestinal diseases and conditions

Research and development services for pharmaceutical preparations and substances; disease management services in the nature of providing patients and health care providers with information on managing the care of patients with specific diseases and on treatments for specific diseases; providing health and pharmaceutical information services; and health and pharmaceutical consulting services

providing medical information in the nature of medical information for professionals, patients, consumers, and the general public regarding pharmaceutical products for treatment purposes

PHARMACEUTICAL PREPARATIONS FOR THE PREVENTION AND TREATMENT OF GASTROINTESTINAL DISEASES

Pharmaceutical preparation, namely, a drug to treat opioid-induced constipation

topical preparation for treatment of inflammatory and pruritic dermatoses

Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases

The mark consists of a half-circle of teal-colored gradient dots with "EST." to the left and "2023" to the right in teal over the words "OPIOID-INDUCED CONSTIPATION" in purple over the words "AWARENESS DAY" in red over "DECEMBER 5" in teal.

EST TWO ZERO TWO THREE OPIOID-INDUCED CONSTIPATION AWARENESS DAY DECEMBER FIVE; EST TWENTY TWENTY THREE OPIOID-INDUCED CONSTIPATION AWARENESS DAY DECEMBER FIVE; EST TWO THOUSAND TWENTY THREE OPIOID-INDUCED CONSTIPATION AWARENESS DAY DECEMBER FIVE

Providing health information

"TREATMENT IN GASTROENTEROLOGY"

The mark consists of the round outline of a clock face with several short straight marks indicating hours. Near the center is "PM" and "AM" separated by the hour and minute hands, with the words "SPLIT DOSING" below them.